In these challenging times of the COVID-19 pandemic, our priority at George Clinical is to ensure that we keep our employees, patients, investigator sites, clients and partners safe and healthy. 

The importance of advancing our mission to improve the health of millions of people worldwide is even more evident at this time and we are committed to ensuring that our clinical projects continue to the best extent possible in the midst of the challenges we face.

Our hearts and thoughts go out to those affected by this pandemic and we appreciate the healthcare workers, local communities, businesses and governments around the world who are on the front line working to manage the evolving situation.  Please know that we are vigilantly monitoring the COVID-19 situation around the globe and have precautions in place to ensure the continuity of our research.

We understand the situation to be fluid and evolving, so we have implemented measures in all of our offices globally in line with WHO and local government health and travel advice.  All our employees have access to flexible working options based on local situations. We have strict processes on safety and hygiene and relevant hygiene tools are provided to our staff as appropriate. To mitigate risk, we have also put a hold on all non-essential travel.

To ensure our projects are progressing as best as possible, we assess the risks posed by COVID-19 and their impact to study subjects, progress and budget. Project-specific mitigation plans have been implemented to ensure all risks are well considered, including increased remote management of our clinical trials if on-site visits are not possible.  In our assessment, we also reference the guidance issued by the US FDA on the Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic to assure patient safety and trial quality during this challenging time. As the development of the COVID-19 outbreak is dynamic, these plans are also being reviewed and updated continuously

We recognize that these are unsettling times and COVID-19 presents challenges that will take time to subside, however rest assured our teams thrive on vigilance and professionalism and are there to serve you effectively.

Stay safe and healthy.

 

James Cheong
Chief Executive Officer, George Clinical